Infliximab as an alternative treatment for Behçet disease when other therapies fail

J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):212-5. doi: 10.1097/MPG.0b013e3181346b60.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / pathology
  • Child
  • Colonoscopy
  • Female
  • Humans
  • Infliximab
  • Treatment Outcome
  • Ulcer / drug therapy
  • Ulcer / etiology
  • Ulcer / pathology

Substances

  • Antibodies, Monoclonal
  • Infliximab